A Relative Bioavailability Study of Different Processes of SHR2554 Tablets in Healthy Adult Subjects

NCT05049083 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

28

Enrollment

INDUSTRY

Sponsor class

Conditions

Lymphoma

Interventions

DRUG: New Process SHR2554 tablet、Former Process SHR2554 tablet
DRUG: Former Process SHR2554 tablet、New Process SHR2554 tablet

Sponsor

Jiangsu HengRui Medicine Co., Ltd.